Skip to main content
OpenTrials
Completed

NCT Number: NCT04911842

Midline Failures: A Comparison Between a Hydrophilic Biomaterial and Thermoplastic Polyurethane

Retrospective chart review to evaluate and compare the rate of failures between midlines made from different materials

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Joseph Bunch

Romeoville, Illinois, 60446, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who have been inserted with the HydroMID by the vascular access group
  • Subjects who have been inserted with a competitor 4 Fr single lumen by the vascular access team

Exclusion criteria

  • Any off-label use (PICC lines cut to be midlines for any manufacturer)

Treatment and study plan

HydroMID

Device

Hydrophilic biomaterial

TPU

Device

Thermoplastic polyurethane

Primary outcomes

  1. The primary objective of this chart review is to evaluate the rates of failure of midlines made from different materials.

    Time frame: retrospective review- March 2021 through May 2021

Secondary outcomes

  1. To compare the proportion of times the midline was used to successfully complete prescribed length.

    Time frame: retrospective review- March 2021 through May 2021

Sponsors and collaborators

Lead sponsor

Access Vascular Inc

Industry

Registry information

Official study title

Midline Failures: A Comparative, Retrospective Chart Review

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Jun 3, 2021
Registry last updated
Feb 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.